Influence of maternal antibodies on Chlamydophila psittaci-specific immune responses in turkeys elicited by naked DNA

Vaccine

Volumn 22, Issue 13-14, 2004, Pages 1616-1623

  Van Loock, M ^a   Lambin, S ^a   Volckaert, G ^b   Goddeeris, B M ^a,c   Vanrompay, D ^c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b LABORATORY OF GENE TECHNOLOGY   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

Chlamydophila psittaci; DNA vaccination; Maternal antibodies

Indexed keywords

MATERNAL ANTIBODY; NAKED DNA; OUTER MEMBRANE PROTEIN; PLASMID DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; BACTERIAL INFECTION; BACTERIAL STRAIN; CELLULAR IMMUNITY; CHLAMYDOPHILA PSITTACI; CLOACA; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; HELPER CELL; IMMUNE RESPONSE; IMMUNITY; INOCULATION; LYMPHOCYTE PROLIFERATION; MEMORY CELL; NONHUMAN; NOSE; PERIPHERAL LYMPHOCYTE; PHARYNX; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; PROVOCATION TEST; SEROTYPE; SYMPTOM; TURKEY (BIRD); VACCINATION;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CHLAMYDOPHILA PSITTACI; DNA, BACTERIAL; EGGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; INJECTIONS, INTRAMUSCULAR; LYMPHOCYTES; PSITTACOSIS; RESPIRATORY SYSTEM; TURKEYS; VACCINATION; VACCINES, DNA;

EID: 1842584473     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.10.044     Document Type: Article

References (45)

1. Everett K.D.E., Bush R.M., Andersen A.A. Emended description of the order Chlamydiales, each containing one monotypic genus, revised taxanomy of the family Chlamydiaceae with descriptions of five new species, and standards for the identification of organisms. Int. J. Syst. Bacteriol. 49(2):1999;415-440.
2. Vanrompay D., Mast J., Ducatelle R., Haesebrouck F., Goddeeris B. Chlamydia psittaci in turkeys: pathogenesis of infections in avian serovars A, B and D. Vet. Microbiol. 47(3-4):1995;245-256.
3. Vanrompay D., Ducatelle R., Haesebrouck F., Hendrickx W. Primary pathogenicity of an European isolate of Chlamydia psittaci from turkey poults. Vet. Microbiol. 38(1-2):1993;103-113.
4. Hall C.F., Glass S.E., Grimes J.E., Moore R.W. An epidemic of ornithosis in Texas turkeys in 1974. Southwest Vet. 28:1975;19-21.
5. Hedberg K., White K.E., Forfang J.C., Korlath J.A., Friendshuh K.A., Hedberg C.W.et al. An outbreak of psittacosis in Minnesota turkey industry workers: implications for modes of transmission and control. Am. J. Epidemiol. 130(3):1989;569-577.
6. Newman J.A. Chlamydia spp. infection in turkey flocks in Minnesota. J. Am. Vet. Med. Assoc. 195(11):1989;1528-1530.
7. Gosbell I.B., Ross A.D., Turner I.B. Chlamydia psittaci infection and reinfection in a veterinarian. Aust. Vet. J. 77(8):1999;511-513.
8. Soni R., Seale J.P., Young I.H. Fulminant psittacosis requiring mechanical ventilation and demonstrating serological cross-reactivity between Legionella longbeachae and Chlamydia psittaci. Respirology. 4(2):1999;203-205.
9. Tan T.W., Herring A.J., Anderson I.E., Jones G.E. Protection of sheep against Chlamydia psittaci infection with a subcellular vaccine containing the major outer membrane protein. Infect. Immun. 58(9):1990;3101-3108.
10. Jones G.E., Jones K.A., Machell J., Brebner J., Anderson I.E., How S. Efficacy trials with tissue-culture grown, inactivated vaccines against chlamydial abortion in sheep. Vaccine. 13(8):1995;715-723.
11. Sandbulte J., TerWee J., Wigington K., Sabara M. Evaluation of Chlamydia psittaci subfraction and subunit preparations for their protective capacities. Vet. Microbiol. 48(3-4):1996;269-282.
12. Giadinis N., Koptopoulos G., Roubles N., Siarkou V., Papasteriades A. Selenium and vitamin E effect on antibody production of sheep vaccinated against enzootic abortion (Chlamydophila psittaci). Comp. Immunol. Microbiol. Infect. Dis. 23(2):2000;129-137.
13. Vanrompay D., Cox E., Volckaert G., Goddeeris B. Turkeys are protected from infection with Chlamydia psittaci by plasmid DNA vaccination against major outer membrane protein. Clin. Exp. Immunol. 118(1):1999a;49-55.
14. Vanrompay D., Cox E., Vandenbussche F., Volckaert G., Goddeeris B. Protection of turkeys against Chlamydia psittaci challenge by gene gun-based DNA immunisations. Vaccine. 17(20-21):1999;2628-2635.
15. Vanrompay D., Cox E., Kaiser P., Lawson K., Van Loock M., Volckaert G.et al. Protection of turkeys against Chlamydophila psittaci challenge by parenteral and mucosal inoculations and the effect of turkeys interferon-gamma on genetic immunisation. Immunology. 103(1):2001;106-112.
16. + T cells in antichlamydial immunity defined by Chlamydia-specific T-lymphocyte clones. Infect. Immun. 62(11):1994;5195-5197.
17. Morrison R.P., Feilzer K., Tumas D.B. Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection. Infect. Immun. 63(12):1995;4661-4668.
18. Stagg A.J., Tuffrey M., Woods C., Wunderink E., Knight S.C. Protection against ascending infection of the genital tract by Chlamydia trachomatis is associated with recruitment of major histocompatibility complex class II antigen presenting cells into uterine tissue. Infect. Immun. 66(8):1998;3535-3544.
19. Beagley K.W., Timms P. Chlamydia trachomatis infection: incidence, health costs and prospects for vaccine development. J. Reprod. Immunol. 48(1):2000;47-68.
20. + T cells. Infect. Immun. 68(12):2000;6979-6987.
21. Yang X. Role of cytokines in Chlamydia trachomatis protective immunity and immunopathology. Curr. Pharm. Des. 9(1):2003;67-73.
22. Igietseme J.U., Murdin A. Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes. Infect. Immun. 68(12):2000;6798-6806.
23. Vanrompay D., Butaye P., Sayada C., Ducatelle R., Haesebrouck F. Characterization of European avian Chlamydia psittaci strains using omp1 gene restriction mapping and serovar-specific monoclonal antibodies. Res. Micrbiol. 148(4):1997;327-333.
24. Vanrompay D., Ducatelle R., Haesebrouck F. Diagnosis of avian chlamydiosis: specificity of the modified Giménez staining on smears and comparison of the sensitivity of isolation in eggs and three different cell cultures. J. Vet. Med. B. 39(2):1992;105-112.
25. Mayer A, Bachmann PA, Bibrack B, Wittmann G. Virologische Arbeitsmethoden, Bd I. Jena: Gustav Fischer Verlag; 1974. p. 35.
26. Vanrompay D., Cox E., Mast J., Goddeeris B., Volckaert G. High-level expression of Chlamydia psittaci major outer membrane protein in COS cells and in skeletal muscles of turkeys. Infect. Immun. 66(11):1998;5494-5500.
27. Vanrompay D., Van Nerom A., Ducatelle R., Haesebrouck F. Evaluation of five immunoassays for detection of Chlamydia psittaci in cloacal and conjunctival specimens from turkeys. J. Clin. Microbiol. 32(6):1994;1470-1474.
28. Novak M., Moldoveanu Z., Schafer D.P., Mestecky J., Compans R.W. Murine model for evaluation of protective immunity to influenza virus. Vaccine. 11(1):1993;55-60.
29. Vanrompay D., Butaye P., Van Nerom A., Ducatelle R., Haesebrouck F. The prevalence of Chlamydia psittaci infections in Belgian commercial turkey poults. Vet. Microbiol. 54(1):1997a;85-93.
30. Mast J., Goddeeris B.M. Development of immunocompetence of broiler chickens. Vet. Immunol. Immunopathol. 70(3-4):1999;245-256.
31. Manickan E., Karem K.L., Rouse B.T. DNA vaccines: a modern gimmick or a boon to vaccinology? Crit. Rev. Immunol. 17(2):1997;139-154.
32. Siegrist C.A., Lambert P.H. Immunization with DNA vaccines in early life: advantages and limitations as compared to conventional vaccines. Springer Semin. Immunopathol. 19(2):1997;233-243.
33. Hassett D.E., Zhang J., Whitton J.L. Neonatal DNA immunization with a plasmid encoding an internal viral protein is effective in the presence of maternal antibodies and protects against subsequent viral challenge. J. Virol. 71(16):1997;7881-7888.
34. Martinez X., Brandt C., Saddallah F., Tougne C., Barrios C., Wild F.et al. DNA immunization circumvents deficient induction of T helper type 1 and cytotoxic T lymphocyte responses in neonates and during early life. Proc. Natl. Acad. Sci. U.S.A. 94(16):1997;8726-8731.
35. Siegrist C.A., Saddallah F., Tougne C., Martinez X., Kovarik J., Lambert P.H. Induction of neonatal TH1 and CTL responses by live viral vaccines: a role for replication patterns within antigen presenting cells? Vaccine. 16(14-15):1998;1473-1478.
36. Hassett D.E., Zhang J., Slifka M., Whitton J.L. Immune responses following neonatal DNA vaccination are long-lived, abundant, and qualitatively similar to those induced by conventional immunization. J. Virol. 74(6):2000;2620-2627.
37. Schlereth B., Rose J.K., Buonocore L., ter Meulen V., Niewiesk S. Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies. J. Virol. 74(10):2000;4652-4657.
38. Weeratna R.D., Brazolot Millan C.L., McCluskie M.J., Davis H.L. CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice. FEMS Immunol. Med. Microbiol. 32(1):2001;65-71.
39. Premenko-Lanier M., Rota P.A., Rhodes G., van Amerongen G., Agafonov A.P., Nechaeva E.A.et al. DNA vaccination of infants in the presence of maternal antibody: a measles model in primate. Virology. 307(1):2003;67-75.
40. Hafez HM, Sting R, Jodas S, Stadler A. Chlamydia psittaci infections in meat turkey: investigations on the interaction with other avian infectious agents. In: Proceedings of the First International Symposium on Turkey Diseases, Berlin, 19-21 February 1998, p. 208-17.
41. Pertmer T.M., Oran A.E., Moser J.M., Madorin C.A., Robinson H.L. DNA vaccines for influenza virus: differential effects of maternal antibody on immune responses to hemagglutinin and nucleoprotein. J. Virol. 74(17):2000;7787-7793.
42. Radu D.L., Antohi S., Bot A., Miller A., Mirarchi A., Bona C. Effect of maternal antibodies on influenza virus-specific immune response elicited by inactivated virus and naked DNA. Scand. J. Immunol. 53(5):2001;475-482.
43. Bot A., Bona C. Genetic immunization of neonates. Microbes Infect. 4(4):2002;511-520.
44. Stittelaar K.J., de Swart R.L., Vos H.W.et al. Priming of measles virus-specific humoral- and cellular-immune responses in macaques by DNA vaccination. Vaccine. 20(23-24):2002;2022-2026.
45. Wang Y., Xiang Z., Pasquini S. Ertl HCJ. Effect of passive immunization or maternally transferred immunity on the antibody response to a genetic vaccine to rabies virus. J. Virol. 72(3):1998;1790-1796.